Faculty Collaboration Database

1. Narra RK, Shah NN. Allogenic transplant for non-hodgkin lymphoma Hematopoietic Cell Transplantation for Malignant Conditions. 1 January 2019:209-229.

1. Talha Badar, Ravi Narra, Alice Mims, Rory M Shallis, Guilherme Sacchi De Camargo Correia, Cameron Hunter, Vamsi K Kota, Shreya Desai, Anand Ashwin Patel, Adam S Duvall, Neil Palmisiano, Emily K Curran, Omer Zulfa, Anjali S Advani, Ehab L Atallah, Mark R Litzow; ‘Achievement of Undetectable BCR:: ABL1 (uBCR:: ABL1) Is Predictive of Improved Survival in Philadelphia Chromosome Positive (Ph+ ve) Acute Lymphoblastic Leukemia (ALL) Patients Not Receiving Allogeneic Stem Cell Transplantation’; Blood 142, 1464, presented at ASH-2023, San Diego, USA

2. Binod Dhakal, Meera Mohan, Ravi Narra, Katie Palen, Aniko Szabo, Tyce Kearl, Gayathri Ravi, Susan Bal, Bryon D Johnson, Marcelo Pasquini, Anita D'Souza, Parameswaran N Hari, Luciano Costa; ‘Dual Targeting of Slamf-7 and CD38 in Mulitple Myeloma (MM): A Phase II Study of Isatuximab, Elotuzumab, Pomalidomide and Dexamethasone (Isa-EloPD) in Relapsed and/or Refractory MM (RRMM)’; Blood 142, 3379, presented at ASH-2023, San Diego, USA

3. Mingqian Lin, Aniko Szabo, Liliana Pezzin, Jing Dong, Binod Dhakal, Meera Mohan, Ravi Narra, Marcelo Pasquini, Anita D'Souza’; ‘Does Socioeconomic Status Have an Impact on Light Chain (AL) Amyloidosis Disease Characteristics and Outcomes?’ Blood 142, 4783, presented at ASH-2023, San Diego, USA

4. James Fan Wu, Noel Estrada-Merly, Binod Dhakal, Meera Mohan, Ravi Kishore Narra, Marcelo Pasquini, Jean Esselmann, Areyl Goff, Catherine E Skoog, Anita D'Souza; ‘Racial Disparities in Autologous Stem Cell Transplant Utilization in Multiple Myeloma Persist Despite Referral to a Transplant Center’ Blood 142, 7346; presented at ASH 2023, San Diego, USA

5. Talha Badar, Ehab Atallah, Ravi Narra, Alice Mims, Vamsi Kota, Shreya Desai, Guilherme Sacchi de Camargo Correia, Anand Patel, Adam Duvall, Neil Palmisiano, Emily Curran, Zulfa Omer, Rory M Shallis, Anjali Advani, Mark Litzow; ‘P354: MULTI-INSTITUTIONAL STUDY EVALUATING THE IMPACT ON SURVIVAL OF NEWER TREATMENT COMBINATIONS AND ALLOGENEIC STEM CELL TRANSPLANTATION IN PHILADELPHIA CHROMOSOME POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA’; HemaSphere; 2023, 7/S3/e9392932, Presented at EHA 2023

6. Abhishek Janardan, Hammons Lindsay, Aniko Szabo, Vineel Bhatlapenumarthi, Evanka Annyapu, Binod Dhakal, Ravi Kishore Narra, Samer Al Hadidi, Sabarinath Venniyil Radhakrishnan, Divaya Bhutani, Sharmilan Thanendrarajan, Janz Siegfried, Maurizio Zangari, Suzanne Lentzsch, Frits van Rhee, Anita D'Souza, Rajshekhar Chakraborty, Carolina D Schinke, Meera Mohan; ‘Changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody therapy in patients with relapsed refractory multiple myeloma (RRMM)’. Journal of Clinical Oncology 2023, 41, 16-suppl, 8019. Presented at ASCO-2023

7. Ravi Kishore Narra, MD MS, Ehab L. Atallah, MD, Sameem Abedin, MD, Lyndsey Runaas, MD, Laura Michaelis, MD, Guru Subramanian Guru Murthy, MBBS. Assessment of Comorbidities and Their Association with Outcomes in Adults with Acute Lymphoblastic Leukemia (ALL) Using Various Comorbidity-Based Scoring Systems; Abstract #2689. Presented at: American Society of Hematology 64th Annual Meeting & Exposition, New Orleans, LA, December 2022

8. Hanrahan J, Seymour L, Beckius A, Welter D, Kastner M, Ehrlich V, Broge-Reynen K, Rodgers M, Michaelis LC, Runaas L, Atallah EL, Abedin S, Guru Murthy GS, Ravi NK, Fournogerakis M, Schmitz J, Viitala A, Larsen E, Essenmacher A, George G, Johnston K, Carlson K, Held N. Standardized Communication Tool Improves Inpatient-Outpatient Care Transitions for Adults with Acute Leukemia. Abstract #2226. Presented at: American Society of Hematology 64th Annual Meeting & Exposition, New Orleans, LA, December 2022

9. Ravi Kishore Narra, MD MBBS, Ehab L. Atallah, MD, Mehdi Hamadani, MD, Guru Subramanian Guru Guru Murthy, MBBS; “Population Level Outcomes of Chronic Lymphocytic Leukemia in the Era of Targeted Agents- Analysis of Surveillance Epidemiology and End Results (SEER) Database”; Blood (2019) 134 (Supplement_1): 1757. https://doi.org/10.1182/blood-2019-130211

10. Ravi Kishore Narra, James Jerkins, Aniko Szabo, Gemlyn George, Marcelo Pasquini, Anita D'Souza, Binod Dhakal, Mehdi Hamadani, Hari Parameswaran, Saurabh Chhabra; “Relapse after allogeneic hematopoietic cell transplantation for multiple myeloma (MM): Single center experience”; Volume 19, ISSUE 10, SUPPLEMENT , e273, October 01, 2019; https://doi.org/10.1016/j.clml.2019.09.450’ IMWG-2019E273, OCTOBER 01, 2019, E273, OCTOBER 01, 2019

11. RK Narra, R Wu, A Szabo, M Hamadani, J Jerkins, N Shah, P Hari, S Chhabra; “Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation for Myelofibrosis– A Single Center Experience” HemaSphere: June 2019 - Volume 3 - Issue S1 - p 1036; doi: 10.1097/01.HS9.0000567768.24772.4e; EHA -2019

12. Doron Feinsilber, Cole McCoy, Parameswaran Hari, Patrick C. Foy, Ravi Narra, Timothy S Fenske, Nirav Niranjan Shah, Laura Christian Michaelis, Vidya Kollu, Katrina Angela Mears, Kristin Osinski, Nancy Froggatt, Ehab L. Atallah, Binod Dhakal;” Evaluation and identification of protocols for safe and efficacious institutional administration of intravenous immune globulin in hypogammaglobinemia associated with chronic lymphocytic leukemia, non-Hodgkin lymphoma, and multiple myeloma” J Clin Oncol 36, 2018 (suppl 30; abstr 250) – ASCO Quality symposium 2018

13. Ravi K Narra, Arun K Singavi, Jonathan Thompson, Smitha Menon, James Thomas, Carolyn Oxencis, Mathew Riese, Paul Ritch, Deepak Kilari, Aniko Szabo and Ben George; “Application of comprehensive genomic profiling (CGP) to predict therapeutic response to immune checkpoint inhibitors (ICI)”; Cancer Res July 1 2018 (78) (13 Supplement) 654; DOI: 10.1158/1538-7445.AM2018-654; AACR-2018

14. Jonathan Thomas Kapke, Ravi Narra, Tina Curtis, Dave Atkinson, J. Douglas Rizzo, Laura C. Michaelis; “24-hour cancer clinic: An approach to same-day care” J Clin Oncol 36, 2018 (suppl; abstr 6544); ASCO-2018

15. Saurabh Chhabra, Ravi K. Narra, Binod Dhakal, James Jerkins, Ibrahim Vazirabad, Vatsal Mehra, James Nytes, Matthew W. Anderson, Parameswaran Hari “Sequence-Level Comparison of Unrelated Allogeneic Hematopoietic Cell Transplantation Donor-Recipient Pairs: Clinical Outcomes of Pairs with No Exonic Sequence Differences in the HLA Loci”; Biology of Blood and Marrow Transplantation , Volume 24 , Issue 3 , S418 – ASMBT 2018

16. Ravi Kishore Narra, Arun K. Singavi, Paul S. Ritch, James P. Thomas, Abdel Alqwasmi, Aniko Szabo, Ben George; “Therapeutic relevance of homologous recombination repair (HRR) pathway variants in metastatic colorectal cancer (mCRC).” J Clin Oncol 36, 2018 (suppl 4S; abstr 677) GI-ASCO 2018

17. Guru Murthy, G. S., Narra, R., Dhakal, B., Hamadani, M., Michaelis, L. C., & Atallah, E. (2017). Incidence and Outcomes of T-Cell Acute Lymphoblastic Leukemia (T-ALL) in United States. Blood, 130(Suppl 1), 2575. ASH 2017

18. Guru Murthy, G. S., Narra, R., Dhakal, B., Hamadani, M., Michaelis, L. C., & Atallah, E. (2017). Recent Trends in the Incidence and Outcomes of Acute Promyelocytic Leukemia in United States. Blood, 130(Suppl 1), 2578 ASH 2017

19. Dhakal, B., Narra, R., Smunt, T., Canadeo, A., Chhabra, S., d'Souza, A., Gyawali, B., Hari, P., & Niraula, S. (2017). Incremental Financial and Health-Related Burden of Novel Drugs Used in the Treatment of Relapsed and/or Refractory Multiple Myeloma (RRMM): A Meta-Analysis of Phase III Randomized Controlled Trials (RCTs). Blood, 130(Suppl 1), 3403.

20. Ravi Narra MD, Saurabh Chhabra MD, Swapna Narayanaraogari MD, Aniko Szabo PhD, Mehdi Hamadani MD, Marcelo Pasquini MD MS, Nirav Shah MD, Parameswaran Hari MD MS MRCP.” Allogeneic hematopoietic cell transplantation (alloHCT) in the eighth decade: Age is just a number” ASCO (American Society of Clinical Oncology)-2017, Chicago, June 2017. J Clin Oncol 35, 2017 (suppl; abstr 7045)

21. Swapna Narayana, Saurabh Chhabra, Ravi Narra, Aniko Szabo, Mehdi Hamadani, Marcelo C. Pasquini, Nirav Shah, Parameswaran Hari; “Allogeneic hematopoietic cell transplantation for myelofibrosis (MF) in high risk patients”. ASCO (American Society of Clinical Oncology)-2017, Chicago, June 2017 J Clin Oncol 35, 2017 (suppl; abstr 7062)

22. Bishan Chakravarthy, MD, Ravi Narra, MD, Nikhil Parikh, MD, Marcello Pasquini, MD; “A rare case of crystal storing histiocytosis”; American College of Physicians (ACP) Regional conference, Chicago, IL, November 2012

23. Ravi Narra, MD, Juan Chediak, MD, Laura Concannon, MD; “Heparin induced thrombosis without thrombocytopenia with positive Lupus Anticoagulant” American College of Physicians (ACP) National conference, San Diego, April 2011

24. Ravi Narra, MD, Ann M Mauer, Mohammed Samee, MD. “Chylothorax; A rare complication of Kaposi Sarcoma, Novel treatment with Octreotide” American College of Physicians (ACP) Regional conference, Chicago, IL, October 2011

25. Srini Mukundan, Ravi Narra, MD, Ann M Mauer, MD; “A suspicious lesion on the Face-Muir Torre Syndrome” American College of Physicians (ACP) Regional conference, Chicago, IL, October 2011; Won 1ST place

26. Nikhil Parikh, MD; Ravi Narra, MD; Mercy Chandrasekharan, MD “Colonic Lymphoma in an asymptomatic Patient-Management option”; American College of Physicians (ACP) Regional conference, Chicago, IL, October 2011

27. Ravi Narra, MD, Juan Chediak, MD, Laura Concannon, MD; “Heparin induced thrombosis without thrombocytopenia with positive Lupus Anticoagulant” American College of Physicians (ACP) Regional conference, Chicago, IL, October 2010

28. Soamsiri Niwattisiawong, MD, Ravi Narra, MD, Mala Vohra, MD; “A case of Splenic Marginal Zone Lymphoma: A rare type of Non-Hodgkin’s Lymphoma”; American College of Physicians (ACP) Regional conference, Chicago, IL, October 2011

29. Prathima Reddy, MD, Ravi Narra, MD, Mala Vohra, MD; “Asian variant intravascular large B-Cell Non-Hodgkin’s Lymphoma: A case report” American College of Physicians (ACP) Regional conference, Chicago, IL, October 2011

1. Narra RK, Alvarez Argote J, Mesologites T, Dasanu CA. Synchronous Tumors: Adenocarcinoma of the Esophagus and Clear Cell Renal Carcinoma. Conn Med. 2015 Aug;79(7):401-4.

2. Narra RK, Flynn KE, Atallah E. Chronic Myeloid Leukemia-the Promise of Tyrosine Kinase Inhibitor Discontinuation. Curr Hematol Malig Rep. 2017 Oct;12(5):415-423. PMCID: PMC6045428

3. Vazirabad I, Chhabra S, Nytes J, Mehra V, Narra RK, Szabo A, Jerkins JH, Dhakal B, Hari P, Anderson MW. Direct HLA Genetic Comparisons Identify Highly Matched Unrelated Donor-Recipient Pairs with Improved Transplantation Outcome. Biol Blood Marrow Transplant. 2019 May;25(5):921-931.

4. Guru Murthy GS, Hari PN, Szabo A, Pasquini M, Narra R, Khan M, Abedin S, Chhabra S, Dhakal B, D'Souza A, Drobyski WR, Rizzo JD, Runaas L, Shah NN, Shaw B, Saber W, Fenske T, Hamadani M. Outcomes of Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation Performed in the Inpatient versus Outpatient Setting. Biol Blood Marrow Transplant. 2019 Apr;25(4):827-833.

5. Chhabra S, Narra RK, Wu R, Szabo A, George G, Michaelis LC, D'Souza A, Dhakal B, Drobyski WR, Fenske TS, Jerkins JH, Pasquini MC, Rizzo RD, Saber W, Shah NN, Shaw BE, Hamadani M, Hari PN. Fludarabine/Busulfan Conditioning-Based Allogeneic Hematopoietic Cell Transplantation for Myelofibrosis: Role of Ruxolitinib in Improving Survival Outcomes. Biol Blood Marrow Transplant. 2020 May;26(5):893-901.

6. Chhabra S, Szabo A, Glisch C, George G, Narra RK, Harrington A, Jerkins JH, D'Souza A, Dhakal B, Pasquini MC, Hamadani M, Hari PN. Relapse after Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma: Survival Outcomes and Factors Influencing Them. Biol Blood Marrow Transplant. 2020 Jul;26(7):1288-1297.

7. Dhakal B, Narra RK, Giri S, Szabo A, Smunt TL, Ghose S, Pathak LK, Aryal M, Hamadani M, Chhabra S, Janz S, D'Souza A, Hari PN. Association of adverse events and associated cost with efficacy for approved relapsed and/or refractory multiple myeloma regimens: A Bayesian network meta-analysis of phase 3 randomized controlled trials. Cancer. 2020 Jun 15;126(12):2791-2801.

8. Daly B, Michaelis LC, Sprandio JD, Kapke JT, Narra RK, Malosh E, Zervoudakis A, Holland J, Zablocki M. From Theory to Practice: Implementation of Strategies to Reduce Acute Care Visits in Patients With Cancer. Am Soc Clin Oncol Educ Book. 2020 May;40:85-94.

9. Wong M, Narra R, Selim M, Zimmerman MA, Kim J, Padmanabhan A, Hong JC. Human Leukocyte Antigen Class I Antibodies and Response to Platelet Transfusion in Patients Undergoing Liver Transplantation. J Surg Res. 2020 Nov;255:99-105.

10. Ahmed S, Zhao Q, Hanel W, Qazilbash MH, Patel K, Narra R, Kansagra A, Iqbal M, Awan FT, Christian B, Jaglowski SM, Kharfan-Dabaja MA, Hamadani M, Epperla N. Post-relapse survival in Waldenstrom macroglobulinemia patients experiencing therapy failure following autologous transplantation. Hematol Oncol. 2022 Feb;40(1):48-56.

11. Shayeb AM, McManus HD, Urman D, Jani C, Zhang T, Dizman N, Meza L, Sivakumar A, Gan CL, Barata P, Bilen MA, Gao X, Heng D, Pal S, Narra R, Kilari D, Kaymakcalan MD, McGregor B, Choueiri TK, McKay RR. Cabozantinib Safety With Different Anticoagulants in Patients With Renal Cell Carcinoma. Clin Genitourin Cancer. 2023 Feb;21(1):55-62.

12. Hammons L, Szabo A, Janardan A, Bhatlapenumarthi V, Annyapu E, Dhakal B, Al Hadidi S, Radhakrishnan SV, Narra R, Bhutani D, Thanendrarajan S, Janz S, Zangari M, Lentzsch S, Van Rhee F, Crescencio JCR, D'Souza A, Chakraborty R, Mohan M, Schinke C. The changing spectrum of infection with BCMA and GPRC5D targeting bispecific antibody (bsAb) therapy in patients with relapsed refractory multiple myeloma. Haematologica. 2024 Mar 01;109(3):906-914. PMCID: PMC10905074

13. Hammons L, Haider S, Portuguese AJ, Banerjee R, Szabo A, Pasquini M, Chhabra S, Radhakrishnan S, Mohan M, Narra R, Dong J, Janz S, Shah NN, Hamadani M, D'Souza A, Hari P, Dhakal B. Chimeric antigen receptor and bispecific T-cell engager therapies in multiple myeloma patients with prior allogeneic transplantation. Br J Haematol. 2024 Mar;204(3):887-891.

14. Muthiah C, Narra R, Atallah E, Juan W, Szabo A, Guru Murthy GS. Evaluating population-level outcomes in Chronic Lymphocytic leukemia in the era of novel therapies using the SEER registry. Leuk Res. 2024 May;140:107496.

15. Narra RK; “Outcomes of Allogeneic Transplantation in Patients with Age Greater Than or Equal to 70 Years”, CTSI thesis, Medical College of Wisconsin, 2018.

16. Ravi K. Narra, MD, Sai Ravi Pingali, MD, Timothy Fenske, MD; “Early-stage Hodgkin’s Lymphoma”; Hospital physician board review manual; May/June 2017; Volume 12, Part 3

17. Ravi K. Narra, MD, Jasleen Randhawa, MD, Timothy Fenske, MD; “Advanced-stage Hodgkin’s Lymphoma”; Hospital physician board review manual; - September/October 2017; Volume 12, Part 3

18. Badar T, Narra R, Mims AS, Heckman MG, Shallis RM, Fahad S, Hunter C, Kota V, Othman TA, Jonas B, Desai S, de Camargo Correia GS, Patel A, DuVall AS, Palmisiano N, Curran E, Omer Z, Advani A, Atallah E, Litzow M. Impact of induction regimens intensity and allogeneic stem cell transplantation on survival of patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A multi-institutional study. Am J Hematol. 2024 Dec;99(12):2388-2391.

19. Yohay S, Oloyede T, Kim S, Fang X, Dhakal B, Aijaz A, Mohan M, Narra R, Pasquini M, D'Souza A, Hamadani M, Freeman CL, Akhtar OS. Outcomes of frail patients undergoing high-dose chemotherapy and autologous stem cell transplantation for multiple myeloma. Br J Haematol. 2024 Dec;205(6):2370-2375.

20. Wu JF, Estrada-Merly N, Dhakal B, Mohan M, Narra RK, Pasquini MC, D'Souza A. Racial and Ethnic Disparities in Autologous Hematopoietic Cell Transplantation Utilization in Multiple Myeloma Have Persisted Over Time Even After Referral to a Transplant Center. Transplant Cell Ther. 2024 Dec;30(12):1189.e1-1189.e10.